These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 9743450

  • 21. Effect of Omeprazole Administration on the Pharmacokinetics of Oral Extended-Release Nifedipine in Healthy Subjects.
    Zhao L, Sun D, Tan ML, Xu M, Kinjo M, Feng K, Wang H, Lionberger R.
    Clin Pharmacol Ther; 2023 Nov; 114(5):1134-1141. PubMed ID: 37669218
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers.
    Wright CW, Aikman MS, Werts E, Seabolt J, Haeusler JM.
    Clin Ther; 2009 Nov; 31(11):2722-34. PubMed ID: 20110014
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Critical questions concerning the validity of the Bayer study report of "Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration".
    Meyer MC.
    Int J Clin Pharmacol Ther; 2010 Jun; 48(6):405-11; author reply 412-5, 416-8. PubMed ID: 20497749
    [No Abstract] [Full Text] [Related]

  • 29. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY, Liang JP, Hu BQ, Qiu Y, Luo CH, Jiang Y, Lin XP, Yang N.
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [Abstract] [Full Text] [Related]

  • 30. [Role of food interaction pharmacokinetic studies in drug development. Food interaction studies of theophylline and nifedipine retard and buspirone tablets].
    Drabant S, Klebovich I, Gachályi B, Renczes G, Farsang C.
    Acta Pharm Hung; 1998 Sep; 68(5):294-306. PubMed ID: 9805816
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with lamivudine and zidovudine administered concurrently and the effect of food on absorption.
    Moore KH, Shaw S, Laurent AL, Lloyd P, Duncan B, Morris DM, O'Mara MJ, Pakes GE.
    J Clin Pharmacol; 1999 Jun; 39(6):593-605. PubMed ID: 10354963
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of nifedipine derived from a new retard tablet formulation.
    Avgerinos A, Gorrod JW.
    Eur J Drug Metab Pharmacokinet; 1990 Jun; 15(4):273-8. PubMed ID: 2088764
    [Abstract] [Full Text] [Related]

  • 34. Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy.
    Sawada T, Kondo H, Nakashima H, Sako K, Hayashi M.
    Int J Pharm; 2004 Aug 06; 280(1-2):103-11. PubMed ID: 15265551
    [Abstract] [Full Text] [Related]

  • 35. Effect of food on nifedipine sustained-release preparation.
    Ueno K, Kawashima S, Uemoto K, Ikada T, Miyai K, Wada K, Yamazaki K, Matsumoto K, Nakata I.
    DICP; 1989 Sep 06; 23(9):662-5. PubMed ID: 2800577
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H, Sallam AA.
    Clin Ther; 2008 Oct 06; 30(10):1831-43. PubMed ID: 19014838
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Controlled release of glaucocalyxin - a self-nanoemulsifying system from osmotic pump tablets with enhanced bioavailability.
    Yanfei M, Guoguang C, Lili R, Pingkai O.
    Pharm Dev Technol; 2017 Mar 06; 22(2):148-155. PubMed ID: 26400477
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.